209 related articles for article (PubMed ID: 30483764)
21. Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target.
Yang C; Yong L; Liang C; Li Y; Ma Y; Wei F; Jiang L; Zhou H; He G; Pan X; Hai B; Wu J; Xu Y; Liu Z; Liu X
Oncogene; 2020 Jun; 39(24):4711-4727. PubMed ID: 32404987
[TBL] [Abstract][Full Text] [Related]
22. Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells.
Meister MT; Boedicker C; Klingebiel T; Fulda S
Cancer Lett; 2018 Aug; 429():19-28. PubMed ID: 29702195
[TBL] [Abstract][Full Text] [Related]
23. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties.
Wang F; Stappenbeck F; Parhami F
Cells; 2019 May; 8(5):. PubMed ID: 31137846
[TBL] [Abstract][Full Text] [Related]
25. β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.
Zinke J; Schneider FT; Harter PN; Thom S; Ziegler N; Toftgård R; Plate KH; Liebner S
Mol Cancer; 2015 Feb; 14(1):17. PubMed ID: 25645196
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells.
Laner-Plamberger S; Wolff F; Kaser-Eichberger A; Swierczynski S; Hauser-Kronberger C; Frischauf AM; Eichberger T
PLoS One; 2013; 8(9):e75317. PubMed ID: 24058673
[TBL] [Abstract][Full Text] [Related]
27. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
Ko YC; Choi HS; Liu R; Lee DS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
[TBL] [Abstract][Full Text] [Related]
28. Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity.
Lee SJ; Litan A; Li Z; Graves B; Lindsey S; Barwe SP; Langhans SA
Mol Cancer; 2015 Aug; 14():159. PubMed ID: 26286140
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling.
Riobo NA; Haines GM; Emerson CP
Cancer Res; 2006 Jan; 66(2):839-45. PubMed ID: 16424016
[TBL] [Abstract][Full Text] [Related]
30. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS
J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979
[TBL] [Abstract][Full Text] [Related]
31. Garcinone C suppresses colon tumorigenesis through the Gli1-dependent hedgehog signaling pathway.
Chen J; Qiu S; Kim JT; Cho JS; Moon JH; Zhou Y; Auh JH; Lee HJ
Phytomedicine; 2020 Dec; 79():153334. PubMed ID: 32920288
[TBL] [Abstract][Full Text] [Related]
32. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.
Coni S; Mancuso AB; Di Magno L; Sdruscia G; Manni S; Serrao SM; Rotili D; Spiombi E; Bufalieri F; Petroni M; Kusio-Kobialka M; De Smaele E; Ferretti E; Capalbo C; Mai A; Niewiadomski P; Screpanti I; Di Marcotullio L; Canettieri G
Sci Rep; 2017 Mar; 7():44079. PubMed ID: 28276480
[TBL] [Abstract][Full Text] [Related]
33. Role of hedgehog signaling in malignant pleural mesothelioma.
Shi Y; Moura U; Opitz I; Soltermann A; Rehrauer H; Thies S; Weder W; Stahel RA; Felley-Bosco E
Clin Cancer Res; 2012 Sep; 18(17):4646-56. PubMed ID: 22733539
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
McCann CK; Growdon WB; Kulkarni-Datar K; Curley MD; Friel AM; Proctor JL; Sheikh H; Deyneko I; Ferguson JA; Vathipadiekal V; Birrer MJ; Borger DR; Mohapatra G; Zukerberg LR; Foster R; Macdougall JR; Rueda BR
PLoS One; 2011; 6(11):e28077. PubMed ID: 22140510
[TBL] [Abstract][Full Text] [Related]
35. RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.
Zhao X; Ponomaryov T; Ornell KJ; Zhou P; Dabral SK; Pak E; Li W; Atwood SX; Whitson RJ; Chang AL; Li J; Oro AE; Chan JA; Kelleher JF; Segal RA
Cancer Res; 2015 Sep; 75(17):3623-35. PubMed ID: 26130651
[TBL] [Abstract][Full Text] [Related]
36. A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.
Rodriguez-Blanco J; Li B; Long J; Shen C; Yang F; Orton D; Collins S; Kasahara N; Ayad NG; McCrea HJ; Roussel MF; Weiss WA; Capobianco AJ; Robbins DJ
Clin Cancer Res; 2019 Feb; 25(4):1379-1388. PubMed ID: 30487124
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway.
Dhanyamraju PK; Holz PS; Finkernagel F; Fendrich V; Lauth M
Mol Cancer Ther; 2015 Mar; 14(3):727-39. PubMed ID: 25552369
[TBL] [Abstract][Full Text] [Related]
38. The Plk1 kinase negatively regulates the Hedgehog signaling pathway by phosphorylating Gli1.
Zhang T; Xin G; Jia M; Zhuang T; Zhu S; Zhang B; Wang G; Jiang Q; Zhang C
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30578313
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma.
Cho K; Moon H; Seo SH; Ro SW; Kim BK
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948011
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel GLI1 target genes and regulatory circuits in human cancer cells.
Diao Y; Rahman MF; Vyatkin Y; Azatyan A; St Laurent G; Kapranov P; Zaphiropoulos PG
Mol Oncol; 2018 Oct; 12(10):1718-1734. PubMed ID: 30098229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
